NAD+ Therapy in NYC: How This Coenzyme Supports Cellular Energy and Longevity

Nicotinamide adenine dinucleotide — better known as NAD+ — is one of the most important molecules in human biochemistry. It participates in hundreds of enzymatic reactions, sits at the center of cellular energy production, and is required for the activity of sirtuins, the protein family responsible for DNA repair, gene expression regulation, and cellular stress resilience. There is one problem: NAD+ levels fall precipitously with age, dropping by approximately 50% between the ages of 40 and 60 in most tissues.

This decline is not a trivial footnote. Reduced NAD+ availability contributes to mitochondrial dysfunction, impaired DNA repair, neuroinflammation, metabolic slowdown, and the progressive biological aging we observe at the cellular and clinical level. Restoring NAD+ has emerged as one of the most scientifically grounded longevity interventions available today.

At Regen Health Physicians NYC, Dr. Ajit Dhaliwal integrates NAD+ therapy into our comprehensive longevity and wellness programs, offering both IV and subcutaneous NAD+ options calibrated to each patient's physiology and health goals.

Why NAD+ Declines — and Why It Matters

The decline in NAD+ with aging is not passive. Several biological processes actively consume it:

• PARP enzymes — DNA repair enzymes that consume NAD+ in response to DNA strand breaks (which accumulate with age and oxidative stress)
• CD38 — an enzyme expressed by immune cells that degrades NAD+ and is upregulated in aging tissues
• Sirtuins — deacetylase enzymes that depend on NAD+ for activity; as NAD+ falls, sirtuin signaling weakens

The consequence is a vicious cycle: aging depletes NAD+, which impairs the cellular repair mechanisms that would otherwise slow aging.

Clinically, this manifests as fatigue that doesn't resolve with adequate sleep, cognitive slowing, reduced exercise tolerance, metabolic inefficiency, and heightened susceptibility to chronic disease. These are not inevitable. They are in part a reflection of a depletable resource that can be replenished.

What the Research Shows

The science on NAD+ precursors and direct NAD+ supplementation has advanced substantially over the past decade:

• Studies in mouse models have demonstrated remarkable reversal of age-related physiological decline with NAD+ repletion — improved muscle endurance, vascular function, and neurological integrity
• Human trials with NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — oral NAD+ precursors — have shown increases in blood NAD+ levels, improved insulin sensitivity, and enhanced aerobic capacity in older adults
• Intravenous NAD+ bypasses oral bioavailability limitations, achieving rapid, high systemic concentrations that oral precursors cannot reliably match
• Sirtuin activation downstream of NAD+ repletion has epigenetic effects on gene expression patterns associated with cellular rejuvenation

Research in this area is ongoing and the field is evolving rapidly. While NAD+ therapy is not FDA-approved for any specific aging indication, it is used by longevity-focused physicians as a rational, mechanistically sound intervention with an excellent safety profile.

NAD+ Therapy at RHPNY

Evaluation First

Dr. Dhaliwal does not administer NAD+ therapy without first understanding your baseline:

• Metabolic panel, inflammatory markers
• Mitochondrial function proxies (organic acids, oxidative stress markers)
• Current medications and supplements (some interact with NAD+ pathway enzymes)
• Health goals: energy, cognition, athletic recovery, general longevity

This context determines dosing strategy, delivery method, and how NAD+ fits into your broader wellness protocol.

Intravenous NAD+

IV NAD+ is administered over 2–4 hours in our clinical setting. The slow infusion rate matters: faster delivery can cause transient chest tightness, flushing, or nausea. Our nursing staff titrates the drip rate to your comfort throughout the session. Most patients describe a noticeable increase in mental clarity and physical energy during or shortly after the infusion.

Typical protocols range from a loading series of 4–10 infusions over 2–4 weeks, followed by monthly or quarterly maintenance sessions. Athletic patients and those recovering from significant fatigue or post-viral illness often opt for more intensive initial protocols.

Subcutaneous NAD+

For patients who prefer a more convenient ongoing option, subcutaneous NAD+ injections can be self-administered at home following an in-office training session. This approach provides a steady maintenance-level NAD+ repletion between IV sessions.

Oral Precursors

We also guide patients on evidence-backed oral NAD+ precursors (NMN, NR) as adjuncts. While oral bioavailability is lower than IV, high-quality oral precursors provide meaningful support and are useful for patients who cannot visit the clinic regularly.

Who Benefits Most from NAD+ Therapy?

Based on our clinical experience, the patients who tend to respond most strongly include:

• Mid-life adults (40–65) experiencing progressive fatigue, brain fog, or reduced exercise capacity without clear conventional diagnosis
• Post-viral fatigue patients — including those recovering from long COVID — for whom mitochondrial dysfunction appears to be a contributing factor
• High-performance executives and athletes seeking cognitive edge and recovery optimization
• Patients with metabolic syndrome or insulin resistance, where mitochondrial efficiency is impaired
• Those with a strong family history of neurodegenerative disease pursuing preventive neurological support

NAD+ pairs naturally with other longevity interventions we offer — including peptide therapy, hormone optimization, and our regenerative medicine protocols — as part of a synergistic approach to healthspan extension.

What Patients Report

Clinical anecdote carries important caveats, but the consistency of reported experiences is worth noting:

• Improved energy levels and reduced afternoon fatigue
• Enhanced mental clarity and focus
• Better sleep quality
• Improved exercise recovery
• Heightened sense of general wellbeing

These subjective reports align with what we would expect mechanistically from improved mitochondrial function and sirtuin activity.

Starting NAD+ Therapy in NYC

Regen Health Physicians serves NYC patients across Manhattan and the surrounding boroughs, as well as our Salt Lake City location. If you are curious about whether NAD+ therapy belongs in your longevity protocol, the first step is a consultation with Dr. Dhaliwal.

Schedule your longevity consultation to discuss your health goals, review your labs, and build a personalized protocol that may include NAD+, peptides, hormone optimization, and other evidence-based interventions.

---

Medical Disclaimer: NAD+ therapy is not FDA-approved for the treatment or prevention of any specific disease. This content is for informational purposes only. Always consult a qualified physician before beginning NAD+ therapy or any longevity intervention. Individual results vary.